135 related articles for article (PubMed ID: 6157543)
1. Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum.
Peter HH; Dallügge H; Zawatzky R; Euler S; Leibold W; Kirchner H
Eur J Immunol; 1980 Jul; 10(7):547-55. PubMed ID: 6157543
[TBL] [Abstract][Full Text] [Related]
2. Studies of the producer cell of interferon in human lymphocyte cultures.
Kirchner H; Peter HH; Hirt HM; Zawatzky R; Dalügge H; Bradstreet P
Immunobiology; 1979 Aug; 156(1-2):65-75. PubMed ID: 94306
[TBL] [Abstract][Full Text] [Related]
3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
4. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.
Valle MJ; Bobrove AM; Strober S; Merigan TC
J Immunol; 1975 Jan; 114(1 Pt 2):435-41. PubMed ID: 46881
[TBL] [Abstract][Full Text] [Related]
5. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
6. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
[TBL] [Abstract][Full Text] [Related]
7. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
Shore SL; Melewicz FM; Gordon DS
J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
[TBL] [Abstract][Full Text] [Related]
8. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
10. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
Rola-Pleszczynski M
J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
[TBL] [Abstract][Full Text] [Related]
11. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
12. Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.
Hirt HM; Schwenteck M; Becker H; Kirchner H
Clin Exp Immunol; 1978 Jun; 32(3):471-6. PubMed ID: 688696
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T lymphocytes against herpes simplex virus type i: role of accessory cells and amplifying factor.
Rouse BT; Lawman MJ
J Immunol; 1980 May; 124(5):2341-6. PubMed ID: 6245140
[TBL] [Abstract][Full Text] [Related]
14. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
Bukowski JF; Welsh RM
J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
Lee KC; Berry D
J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation by Corynebacterium parvum in normal humans.
Hokland P; Ellegaard J; Heron I
J Immunol; 1980 May; 124(5):2180-5. PubMed ID: 6154095
[TBL] [Abstract][Full Text] [Related]
18. In vitro production and cellular origin of murine type II interferon.
Sonnenfeld G; Mandel AD; Merigan TC
Immunology; 1979 Apr; 36(4):883-90. PubMed ID: 374263
[TBL] [Abstract][Full Text] [Related]
19. Sequential production of IFN-alpha and immune-specific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus.
Green JA; Yeh TJ; Overall JC
J Immunol; 1981 Sep; 127(3):1192-6. PubMed ID: 6167619
[TBL] [Abstract][Full Text] [Related]
20. High cytotoxic activity against herpes simplex virus type 1 infected targets found in murine peritoneum.
Brownridge E; Lopez C
Nat Immun Cell Growth Regul; 1986; 5(6):294-304. PubMed ID: 2432414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
